Vaxxel (private company)

See something wrong or missing? Let us know
Offices:Lyon
Business model:B2B

Vaxxel is a French biotech company that develops the first intranasal live attenuated and multivalent viral vaccine against HMPV and HRSV for paediatric and elderly indications from an HMPV-derived vaccine platform.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 1.32M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Vaxxel

Name Criteria
France Pharmedigroup
70%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Pila Pharma
70%
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France PEP-Therapy
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Nanolyze
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Mytos
70%
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain Nanoligent
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Beckley Psytech
65%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Sweden Cinclus Pharma
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one other investor: found 1
Sweden iCellate
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one other investor: found 1
Denmark Octarine Bio
65%
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top